You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Chloride patents expire, and what generic alternatives are available?

Sodium Chloride is a drug marketed by Abbott, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Hospira, Miles, Otsuka Icu Medcl, Medefil Inc, Hikma, Nexus, Spectra Mdcl Devices, Fresenius Medcl, Gvs Tm, Laboratorios Grifols, Liebel-flarsheim, Icu Medical Inc, Jubilant Cadista, Nephron, Taro, and Abraxis Pharm. and is included in fifty-four NDAs.

The generic ingredient in SODIUM CHLORIDE is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHLORIDE?
  • What are the global sales for SODIUM CHLORIDE?
  • What is Average Wholesale Price for SODIUM CHLORIDE?
Summary for SODIUM CHLORIDE
US Patents:0
Applicants:20
NDAs:54

US Patents and Regulatory Information for SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 077407-002 Aug 11, 2006 AP RX No Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Liebel-flarsheim SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 021569-001 Jul 27, 2006 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-004 Nov 9, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Fresenius Kabi Usa SODIUM CHLORIDE 23.4% sodium chloride INJECTABLE;INJECTION 217796-001 Jul 11, 2023 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario and Fundamentals Analysis of Sodium Chloride

Last updated: February 20, 2026

What is Sodium Chloride and Why Is It Significant in Pharmaceuticals?

Sodium chloride (NaCl) is a chemical compound widely used in medical, pharmaceutical, and industrial applications. In pharmaceuticals, sodium chloride solutions are used for intravenous (IV) rehydration, maintenance fluids, and as a stabilizer in drug formulations. Due to its essential role in clinical treatments, the compound maintains steady demand.

Market Overview and Valuation

The global sodium chloride market was valued at approximately USD 12.4 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.2% through 2030, reaching over USD 18 billion. Growth drivers include increased use in medical products, food processing, and industrial applications.

Key Segments:

  • Pharmaceutical: 25% of total market; used mainly in IV solutions, dialysis, and as a stabilizer [1].
  • Industrial: 45%; used in chemical manufacturing, de-icing, and water treatment.
  • Food: 20%; as a preservative and flavor enhancer.
  • Other: 10%; including agriculture and textile processing.

Production and Supply Chains

Major producers include:

Company Capacity (MT/year) Market Share Location
Cargill Inc. 2 million 20% United States, Brazil
Compass Minerals 1.7 million 17% United States, UK
Olam International 1.2 million 12% Singapore, Australia
Local and regional producers Remaining - Global

Supply chains rely on natural salt deposits or seawater evaporation. Stability of supply depends on geography, environmental policies, and global trade conditions.

Regulatory Environment and Market Dynamics

The pharmaceutical application faces stringent regulatory standards:

  • USP (United States Pharmacopeia): Sets purity and safety standards.
  • European Pharmacopoeia: Similar standards for European markets.
  • FDA approval: Required for IV solutions and injectable forms.

The industry is impacted by environmental regulations concerning salt extraction and environmental sustainability policies.

Investment Fundamentals

Cost Structure:

  • Raw salt costs: USD 15–50 per MT, depending on quality and extraction method.
  • Processing expenses: USD 50–150 per MT, including purification and packaging.
  • Logistics: USD 20–70 per MT, influenced by transportation and geographic origin.

Pricing Trends:

  • Average wholesale price: USD 150–250 per MT.
  • Price stability benefits from high demand in pharma and low production variability.

Competitive Position:

  • High barriers to entry due to regulatory standards and large capital investment.
  • Existing producers benefit from economies of scale.
  • New entrants face regulatory, environmental, and logistical hurdles.

Risks:

  • Fluctuations in raw material costs.
  • Regulatory changes impacting production or approval.
  • Disruption in supply chains due to geopolitical or environmental factors.

Investment Outlook

The steady, inelastic demand in medical sectors provides some stability. Growth hinges on expanding applications in emerging markets and innovations in pharmaceutical formulations. The segment's low technological barrier reduces competitive risks but constrains high-margin opportunities.

Sodium chloride’s status as an essential commodity and pharmacy staple makes it a relatively low-risk, low-return investment. Returns depend on scale efficiencies and cost control rather than innovation.

Key Takeaways

  • The market is mature, with consistent demand driven by pharmaceutical needs.
  • Supply is concentrated among few large producers, limiting price volatility.
  • Regulatory and environmental risks are manageable but require ongoing compliance.
  • Investment opportunities are primarily in production efficiency and logistics, not product innovation.

FAQs

1. Is sodium chloride a good long-term investment?
It offers stability due to ongoing demand in pharmaceuticals but limited growth prospects. Suitable for value-focused investors.

2. What are the main growth catalysts?
Expansion in emerging markets and increased use in medical treatments.

3. How sensitive is the market to raw material price changes?
Relatively low. Raw salt costs constitute a small part of overall expenses; price volatility is smoothed by large-scale operations and steady demand.

4. What regulations impact sodium chloride producers?
Environmental regulations restrict salt extraction; pharmaceutical standards set purity and safety benchmarks.

5. Are there notable disruptions in supply chains?
Potential risks include geopolitical issues, environmental restrictions, or natural disasters impacting key production regions.


References

[1] MarketsandMarkets. (2023). Sodium chloride market by application and region. Retrieved from https://www.marketsandmarkets.com

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.